| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 44,251 | 37,263 | 33,357 | 43,396 | | Cost of Revenue | 17,450 | 14,370 | 13,049 | 15,718 | | | Gross Profit | 26,801 | 22,893 | 20,308 | 27,678 | | | Operating Expenses | | Research Development | 4,175 | 3,950 | 3,714 | 3,615 | | Selling General and Administrative | 17,455 | 15,521 | 15,491 | 15,610 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,171 | 3,422 | 1,103 | 8,453 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (42) | 486 | 140 | 1,109 | | Earnings Before Interest And Taxes | 5,129 | 3,908 | 1,243 | 9,562 | | Interest Expense | (113) | 99 | 14 | (79) | | Income Before Tax | 5,242 | 3,809 | 1,229 | 9,641 | | Income Tax Expense | 1,573 | 1,473 | 442 | 3,354 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,669 | 2,336 | 787 | 6,287 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,669 | 2,336 | 787 | 6,287 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,669 | $2,336 | $787 | $6,287 |
|
0.02% Nasdaq 
0.14 (0.95%) 
Income Statement
